Researchers cautioned that study results involving laboratory mouse models do not always translate into clinical treatment of human patients
Researchers used blood platelets and bone marrow cells to deliver potentially curative
to mouse models of the human genetic disorder Hurler syndrome – an often fatal condition that causes organ damage and other medical complications.
Scientists from Cincinnati Children’s Hospital Medical Center and the National Institute of Neurological Disorders and Stroke (NINDS) report their unique strategy for treating the disease the week of Feb. 3-7 in Proceedings of the National Academy of Sciences (PNAS).
Researchers were able to genetically insert into the cells a gene that produces a critical lysosomal enzyme (called IDUA) and then inject the engineered cells into mice to treat the disorder. Follow up tests showed the treatment resulted in a complete metabolic correction of the disease, according to the authors.
“Our findings demonstrate a unique and somewhat surprising delivery pathway for lysosomal enzymes,” said Dao Pan, PhD, corresponding author and researcher in the Division of Experimental Hematology and Cancer Biology at Cincinnati Children’s. “We show proof of concept that platelets and megakaryocytes are capable of generating and storing fully functional lysosomal enzymes, which can lead to their targeted and efficient delivery to vital tissues where they are needed.”
The mice tested in the study modeled human Hurler syndrome, a subset of disease known as mucopolysaccharidosis type I (MPS I), one of the most common types of lysosomal storage diseases. MPS I is a lysosomal storage disease in which people do not make an enzyme called lysosomal alpha-L-iduronidase (IDUA).
IDUA helps break down sugar molecules found throughout the body, often in mucus and fluids around joints, according to the National Library of Medicine/National Institutes of Health. Without IDUA, sugar molecules build up and cause organ damage. Depending on severity, the syndrome can also cause deafness, abnormal bone growth, heart valve problems, joint disease, intellectual disabilities and death.
Enzyme replacement therapy can be used to treat the disease, but it is only temporary and not curative. Bone marrow transplant using hematopoietic stem cells also has been tested on some patients with mixed results. The transplant procedure can carry severe risks and does not always work.
Pan and her colleagues – including Roscoe O. Brady, MD, a researcher at NINDS – report that using platelets and megakaryocytes for gene therapy is effective and could reduce the risk of activating cancer-causing oncogenes in hematopoietic stem cells.
The authors said tests showed that human megakaryocytic cells were capable of overexpressing IDUA, revealing their capacity for potential therapeutic benefit. While engineering megakaryocytes and platelets for infusion into their mouse models of Hurler, the scientists report they were able to release IDUA directly into amply sized extracellular spaces or inside micro-particles as the cells matured or activated. The cells were able to produce and package large amounts of functional IDUA and retained the capacity to cross-correct patient cells.
After infusing mouse models of Hurler with the genetically modified cells, researchers said this led to long-term normalization of IDUA levels in the animal’s blood with versatile delivery routes and on-target preferential distribution to the liver and spleen. The treatment led to a complete metabolic correction of MPS I in most peripheral organs of the mice.
Researchers cautioned that study results involving laboratory mouse models do not always translate into clinical treatment of human patients, and that additional research is needed for this prospective therapy.
The Latest on: Hurler syndrome
[google_news title=”” keyword=”Hurler syndrome” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Hurler syndrome
- Which pitchers have the most career strikeouts for every MLB franchise?on April 23, 2024 at 5:00 pm
Follow us on MSN to see more of our exclusive MLB content. Arizona State alum Jim Palmer spent his entire 19-year career in Baltimore, and is hands down the most accomplished hurler in Orioles history ...
- Cardiac screening can have life-saving impacton April 19, 2024 at 9:59 am
A new Foundation was officially launched last week with the ambitious aim of providing life-saving cardiac screening for young people in County Cavan and across Ireland.
- Public urged to recognise life-saving impact of cardiac screeningon April 19, 2024 at 6:27 am
A new Foundation was officially launched this week with the ambitious aim of providing life-saving cardiac screening for young people in Clare and across Ireland. The Dillon Quirke Foundation was ...
- Quirke family launch charity in hurler Dillon's memoryon April 17, 2024 at 2:11 am
Set up by the Quirke family in memory of their son, the foundation is a registered charity aiming to reduce the number of young people in Ireland dying from SADS. Through a partnership with Advanced ...
- Carl Erskine, Dodgers pitcher and last of ‘Boys of Summer,’ dies at 97on April 16, 2024 at 10:30 am
A standout hurler for Brooklyn in the 1940s and ’50s, he was a close ally of Jackie Robinson, who broke baseball’s color barrier.
- Reck on the Road: Ainsley’s Angels at the Boston Marathonon April 16, 2024 at 9:45 am
Thomas Hicks and Hannah Gosey became the first all-adaptive duo team to complete The Boston Marathon yesterday. Hicks, an accomplished runner and seven time Boston Marathon participant was diagnosed ...
- People in Meath urged to recognise the life-saving impact of cardiac screeningon April 12, 2024 at 12:08 am
The Dillon Quirke Foundation was established by the family of the late Tipperary hurler, Dillon Quirke, who collapsed and died during a hurling match at Semple Stadium in August 2022. Its aim is to ...
- People in Louth urged to recognise the life-saving impact of cardiac screeningon April 11, 2024 at 8:20 am
The Dillon Quirke Foundation was established by the family of the late Tipperary hurler, Dillon Quirke, who collapsed and died during a hurling match at Semple Stadium in August 2022. Its aim is to ...
- Mayo footballer Saoirse Lally attends launch of new charity set up in memory of Tipperary hurler Dillon Quirkeon April 11, 2024 at 8:00 am
Gaelic Players' Association CEO, Tom Parsons, and Mayo footballer Saoirse Lally at the launch of the Dillon Quirke Foundation in Buswells Hotel, Dublin (Pic: The Dillon Quirke Foundation) ...
- Mayo footballer attends launch of new charity set up in memory of Tipp hurleron April 10, 2024 at 10:01 am
On average, 100 young people die in Ireland each year because of Sudden Adult Death Syndrome (SADS). Many of these deaths ... That’s according to Dan Quirke, father of Tipperary hurler Dillon Quirke, ...
via Bing News